Aurobindo Pharma to launch oncology, respiratory products in US by 2021
The company plans to launch first set of biosimilars and vaccines in growth markets during this time
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cliantha Research organises Respiratory Symposium in Mumbai
About 125 industry experts attended the symposium, including senior delegates from pharma, life-science and clinical research…
Zydus Cadila gets US FDA nod to market generic HIV treatment tabs
The product will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad
Vice President of India to meet top 50 pharma CEOs at 70th IPC
70th IPC LOC conducts final review meeting at PHD Chamber
Exactly 40 days before the 70th Indian Pharmaceutical Congress (IPC),…
Shilpa Medicare gets tentative US FDA nod for multiple sclerosis drug
Dimethyl Fumarate delayed release capsules is a generic of Tecfidera
Impact of GST has largely been positive and constructive on pharma sector: Mansukh Mandaviya
The minister also informed that due to discontinuation of Central Sales Tax post-GST, it will reduce transaction costs, as…
LANXESS to strengthen its Indian production sites
Aims to invest around ₹ 1250 crores in the next five years
Record year for pharma packaging and drug delivery innovation: Pharmapack
Event sees more innovation centralising at the Paris hub with entries for the awards and Start-up Hub opening
Lupin receives US FDA approval
Lupin’s Decitabine for Injection, 50 mg/vial, Single-Dose Vial is indicated for the treatment of patients with myelodysplastic…